Psioxus Therapeutics Limited
Records under this name other than the patents Psioxus Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Psioxus Therapeutics Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,716,325 | Treatment of cachexia Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,835,485 | Prevention and treatment of sarcopenia Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,173,186 | A Dosing Regime and Formulations for Type B Adenovirus Formerly held In force · High confidence | In force | High confidence | |
| US 12,350,302 | Dosing Regime and Formulations for Type B Adenoviruses Formerly held In force · High confidence | In force | High confidence | |
| US 9,987,314 | Oncolytic Adenoviruses Armed with Heterologous Genes Formerly held In force · High confidence | In force | High confidence | |
| US 10,034,905 | Group B Adenovirus Modified in the E4ORF4 Region Formerly held In force · High confidence | In force | High confidence | |
| US 11,439,678 | Oncolytic Adenoviruses Armed with Heterologous Genes Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,472,648 | A Method of Making Adenovirus and Corresponding Plasmids Formerly held In force · High confidence | In force | High confidence | |
| US 11,938,159 | Oncolytic Adenoviruses Armed with Heterologous Genes Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,322,152 | Oncolytic Adenovirus Encoding a B7 Protein Formerly held In force · High confidence | In force | High confidence |